Last checked at 2 Aug 2010 12:16
Annual Information Update
LONDON, 2 August 2010. In accordance with Prospectus Rule 5.2, Hikma Pharmaceuticals PLC ("Hikma" or "the Company") (LSE: HIK) sets out below a summary of the information which has been published or made available to the public over the period. The information referred to in this Update was up to date at the time the information was published, but some information may now be out of date.
Stock Exchange Announcements
Announcements made by the Company via RNS, a Regulatory Information Service, may be viewed and downloaded from the Company's market news section on the London Stock Exchange website at (http://www.londonstockexchange.com/prices-and-news/stocks/stocks-and-prices.htm) or from the press releases page on the Company's website at (http://www.hikma.com/investorrelations/rns/). The Stock Exchange announcements made during the period were:
| Date of Announcement | Headline of Announcement |
| 14 May 2009 | Interim Management Statement |
| 14 May 2009 | Result of AGM |
| 19 May 2009 | Director/PDMR Shareholding |
| 29 June 2009 | Director/PDMR Shareholding |
| 5 August 2009 | Total Voting Rights |
| 27 August 2009 | Half Yearly Report |
| 1 October 2009 | Total Voting Rights |
| 1 October 2009 | Additional Listing |
| 16 October 2009 | Director/PDMR Shareholding |
| 20 October 2009 | Blocklisting Interim Review |
| 2 November 2009 | Total Voting Rights |
| 12 November 2009 | Interim Management Statement |
| 18 November 2009 | Director/PDMR Shareholding |
| 18 November 2009 | Director/PDMR Shareholding |
| 19 November 2009 | Director/PDMR Shareholding |
| 1 December 2009 | Director/PDMR Shareholding |
| 1 December 2009 | Total Voting Rights |
| 18 December 2009 | Director/PDMR Shareholding |
| 4 January 2010 | Total Voting Rights |
| 5 January 2010 | Director/PDMR Shareholding |
| 1 February 2010 | Total Voting Rights |
| 1 March 2010 | Notice of Results |
| 10 March 2010 | Total Voting Rights |
| 15 March 2010 | Blocklisting of Shares |
| 17 March 2010 | Preliminary Announcement for 2009 |
| 23 March 2010 | Director/PDMR Shareholding |
| 30 March 2010 | Hikma expands in the Tunisian market |
| 1 April 2010 | Blocklisting Six Monthly return |
| 1 April 2010 | Voting Rights & Capital |
| 7 April 2010 | Director/PDMR Shareholding |
| 8 April 2010 | Director/PDMR Shareholding |
| 9 April 2010 | Director/PDMR Shareholding |
| 9 April 2010 | Director/PDMR Shareholding |
| 9 April 2010 | Annual Financial Report |
| 12 April 2010 | Hikma expands in the Algerian market |
| 20 April 2010 | Director/PDMR Shareholding |
| 23 April 2010 | Director/PDMR Shareholding |
| 5 May 2010 | Voting Rights & Capital |
| 13 May 2010 | Interim Management Statement |
| 13 May 2010 | AGM Statement |
| 26 July 2010 | Voting Rights and Capital |
All of the above announcements were also made by the Company via the NasdaqDubai stock exchange CANDI system. These announcements may be viewed and downloaded from the NasdaqDubai website (www.candi.nasdaq.com).
Documents filed with the Financial Services Authority
The Company has filed the following documents with the Financial Services Authority ("FSA") over the previous 12 months. These documents are available to be viewed via the UKLA's Document Viewing Facility at the Financial Services Authority, 25 the North Colonnade, London, E14 5HS or at the Company's registered office.
| Date | Document |
| 9 April 2010 | Annual Report and Accounts 2009 |
| 9 April 2010 | Notice of 2010 Annual General Meeting |
| 9 April 2010 | Proxy forms for the 2010 Annual General Meeting |
| 9 April 2010 | Sterling and Jordanian Dinar dividend election forms |
Documents filed with Companies House
The Company submitted filings to the Registrar of Companies in England and Wales as detailed in the table below.
| Date Filed | Form | Description |
| 30 July 2010 | SH01 | 31/05/10 statement of capital GBP 19326339 |
| 30 July 2010 | SH01 | 30/04/10 statement of capital GBP 19313279 |
| 23 July 2010 | SH01 | 31/03/10 statement of capital GBP 19260000 |
| 9 June 2010 | AA | Group of companies' accounts made up to 31/12/09 |
| 8 June 2010 | RES01 | Alteration to memorandum and articles |
| 8 June 2010 | RES10 | Authorised allotment of shares and debentures |
| 8 June 2010 | RES09 | Authority to purchase shares other than from capital |
| 8 June 2010 | RES11 | Disapplication of pre-emption rights |
| 26 May 2010 | RES10 | Authorised allotment of shares and debentures |
| 26 May 2010 | RES01 | Alteration to memorandum and articles |
| 26 May 2010 | RES11 | Disapplication of pre-emption rights |
| 19 April 2010 | SH01 | 31/01/10 statement of capital GBP 19176400 |
| 19 April 2010 | SH01 | 30/11/09 statement of capital GBP 19156490 |
| 19 April 2010 | SH01 | 31/12/09 statement of capital GBP 19162760 |
| 16 April 2010 | SH01 | 31/03/10 statement of capital GBP 19260000 |
| 15 October 2009 | AD03 | Register(s) moved to sail address |
| 15 October 2009 | AD02 | Sail address created |
| 29 September 2009 | 363a | Return made up to 08/09/09; bulk list available separately |
| 24 September 2009 | 88(2) | AD 01/07/09-30/07/09 issued share capital GBP IC 18982880/18983480 |
| 24 September 2009 | 88(2) | AD 01/06/09-30/06/09 issued share capital GBP IC 18959440/18982880 |
| 24 September 2009 | 88(2) | AD 01/05/09-30/05/09 issued share capital GBP IC 18940080/18959440 |
| 24 September 2009 | 88(2) | AD 01/04/09-30/04/09 issued share capital GBP IC 18912440/18940080 |
| 24 September 2009 | 88(2) | AD 01/03/09 to 30/03/09 issued share capital GBP IC 18888160/18912440 |
| 25 July 2009 | AA | Group of companies' accounts made up to 31/12/08 |
| 3 June 2009 | RES10 | Authorised allotment of shares and debentures |
| 3 June 2009 | RES13 | Approve remuneration committee report 14/05/2009 |
| 3 June 2009 | RES09 | Authority to purchase shares other than from capital |
| 3 June 2009 | RES11 | Disapplication of pre-emption rights |
Copies of all these documents may be obtained from Companies House, Crown Way, Maindy, Cardiff CF14 3UZ or, if you are a registered user, they may be viewed and downloaded using Companies House Direct at www.direct.companieshouse.gov.uk.
Further Information
Further information about Hikma Pharmaceuticals PLC can be found at our website www.hikma.com. Copies of all documents can be obtained from the Company at the registered office which is located at 13 Hanover Square, London W1S 1HW.
Henry Knowles Company Secretary 2 August 2010
- ENDS -
Enquiries:
| Hikma Pharmaceuticals PLC | ||
| Henry Knowles Company Secretary
| +44 20 7399 2670 | |
| Susan Ringdal Investor Relations Director
| +44 20 7399 2670
| |
| Financial Dynamics | ||
| Ben Atwell/ Julia Phillips | +44 20 7269 7242 | |
| Jonathan Birt/ Matthew Cole | ||
About Hikma
Hikma Pharmaceuticals PLC is a fast growing multinational group focused on developing, manufacturing and marketing a broad range of both branded and non-branded generic and in-licensed products. Hikma's operations are conducted through three businesses: "Branded", "Injectables" and "Generics" based principally in the Middle East and North Africa ("MENA") region, where it is a market leader, the United States and Europe. In 2009, Hikma achieved revenues of $637 million and profit attributable to shareholders of $78 million. For news and other information, please visit www.hikma.com.